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Summary
Synthesis of deoxynucleoside triphosphates (dNTPs) is re-
quired for both DNA replication and DNA repair and is cata-
lyzed by ribonucleotide reductases (RNR), which convert
ribonucleotides to their deoxy forms [1, 2]. Maintaining the
correct levels of dNTPs for DNA synthesis is important for
minimizing the mutation rate [3–7], and this is achieved by
tight regulation of RNR [2, 8, 9]. In fission yeast, RNR is regu-
lated in part by a small protein inhibitor, Spd1, which is
degraded in S phase and after DNA damage to allow upregu-
lation of dNTP supply [10–12]. Spd1 degradation is mediated
by the activity of the CRL4Cdt2 ubiquitin ligase complex
[5, 13, 14]. This has been reported to be dependent onmodu-
lation of Cdt2 levels, which are cell cycle regulated, peaking
in S phase, and which also increase after DNA damage in
a checkpoint-dependent manner [7, 13]. We show here that
Cdt2 level fluctuations are not sufficient to regulate Spd1
proteolysis and that the key step in this event is the interac-
tion of Spd1with the polymerase processivity factor prolifer-
ating cell nuclear antigen (PCNA), complexed onto DNA.
This mechanism thus provides a direct link between DNA
synthesis and RNR regulation.Results and Discussion
High Cdt2 Levels Are Necessary but Not Sufficient
to Induce Spd1 Degradation
Spd1 degradation is mediated by the activity of the CRL4Cdt2
ubiquitin ligase complex, which consists of a scaffold protein
(Cul4), an adaptor protein (Ddb1), and a substrate-recruiting
factor (Cdt2) [5, 13, 14]. As with Sml1 in Saccharomyces cere-
visiae, Spd1 is degraded in S phase and after DNA damage to
allow upregulation of deoxynucleoside triphosphate (dNTP)
levels. This has been reported to be dependent on modula-
tion of Cdt2 levels, which are cell cycle regulated, peaking in
S phase, and which also increase after DNA damage in a
checkpoint-dependent manner [7, 13]. Liu et al. [13, 14] re-
ported that Spd1 degradation in S phase is independent of
DNA damage checkpoint activation but requires both Rad34Present address: Cancer Research UK, Clare Hall Laboratories, South
Mimms, Herts EN6 3LD, UK
*Correspondence: stephen.kearsey@zoo.ox.ac.ukand Chk1 in G2 phase and is driven by increased Cdt2
abundance. Furthermore, Moss et al. [7] reported that Rad3-
dependent elevation of Cdt2 levels following double-strand
break induction is responsible for Spd1 proteolysis and
elevated dNTP levels, facilitating DNA repair.
From previous work, it is not clear whether checkpoint
activation simply serves to elevateCdt2 levels or plays an addi-
tional role required for Spd1 proteolysis. To address this possi-
bility, we expressed Cdt2 at a high level in a manner that was
not dependent on checkpoint activation. Yox1 is an inhibitor
of the Mlu1 binding factor (MBF) [15], which is an activator of
the transcription of several genes, including cdt2. Therefore,
deletion of yox1 results in deregulated cdt2 expression (Fig-
ure 1A, ‘‘log yox1D’’). In a yox1D strain, degradation of Spd1
occurred after DNA damage as in a wild-type strain, but this
was no longer Rad3 dependent (Figure 1B). We carried out
asimilar experimentwith cells arrested inmitosis usingannda3
block; under these conditions, Cdt2 levels were also high (Fig-
ure 1A, ‘‘mitotic-arrested WT’’). Again, degradation of Spd1
followingDNAdamagewas not dependent onRad3 (Figure 1B,
lower panels). These experiments indicate that the only role of
the DNA damage checkpoint in Spd1 proteolysis is to allow
cdt2 expression, and that this requirement can be bypassed
when cdt2 overexpression is achieved by other pathways.
Interestingly, we noted that although Cdt2 levels were high
in mitotically arrested cells, Spd1 levels were not lower than
those observed in exponentially growing cells (Figure 1C)
unless DNA damage was induced (Figure 1B, lower panels).
This observation is at odds with the model where Spd1 regula-
tion is driven only by fluctuations in Cdt2 levels and suggests
that there must be another process induced by DNA damage
and S phase that is rate limiting for Spd1 proteolysis.
Spd1 Proteolysis Requires Chromatin-Bound PCNA
Given that high Cdt2 levels alone do not seem to be sufficient
to induce Spd1 degradation while DNA synthesis is required, it
seems likely that an event involved in replication itself
is necessary for proteolysis. Ubiquitylation of several other
substrates of CRL4Cdt2, such as Cdt1, p21, E2F, DNA pol h,
and Set8, requires interaction of the substrate with the poly-
merase processivity factor proliferating cell nuclear antigen
(PCNA) [16–23]. For Cdt1, Set8, and p21 substrates, it has
been shown that ubiquitylation occurs on chromatin and that
DNA loading of PCNA is required to stimulate substrate ubiq-
uitylation [19, 23]. To determinewhether Spd1 turnover is regu-
lated by this mechanism, we examined whether inactivation of
replication factor C, which blocks loading of PCNA onto DNA,
affected Spd1 degradation. Cells arrested in S phase with
hydroxyurea (HU) required active Rfc1 for Spd1 degradation
(Figure 2A, left panel). Similarly, Spd1 proteolysis seen after
DNAdamagewas also blocked byRfc1 inactivation (Figure 2A,
right panel), and thus these observations suggest that Spd1
ubiquitylation and subsequent proteolysis are dependent on
DNA-associated PCNA. We also observed that after Rfc1
inactivation, Cdt2 levels increased notably but Spd1 accumu-
lated, confirming that elevated Cdt2 levels are necessary but
not sufficient for Spd1 degradation (see Figure S1 available
online).
Figure 1. Increased Expression of cdt2 Is Necessary but Not Sufficient to
Induce Spd1 Proteolysis
(A) Cdt2-TAP levels in exponentially growing (log) or mitotically arrested
wild-type cells (2710) and exponentially growing yox1Dmutant cells (2698).
(B) Western blot analysis showing Spd1-TAP levels after methyl methane-
sulfonate (MMS) addition in a wild-type strain (1766) and in a rad3D (2644)
mutant (upper panels), Spd1-TAP levels after MMS treatment of yox1D
(2711) and rad3D yox1D (2713) cells (middle panels), and Spd1-TAP levels
after MMS treatment of mitotically arrested cells that were either wild-
type for checkpoint function (2678) or DNA damage checkpoint defective
rad3D (2677) mutant (lower panels).
(C) Spd1-TAP levels in exponentially growing (log) or mitotically arrested
wild-type cells (2678). Tubulin is shown as a loading control.
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degradation, we examined a mutant of PCNA that is defective
for CRL4Cdt2-mediated ubiquitylation. Havens et al. [24] re-
cently found that mutating the surface of PCNA that surrounds
the PCNA-interacting protein (PIP) binding site prevents
CRL4Cdt2-mediated proteolysis. This mutation (D122A) has
nomajor effect on binding of thePIPdegron toPCNAbut rather
prevents recruitment of CRL4Cdt2 to PCNA. Strikingly, we
found that PCNAD122A blocked Spd1 proteolysis after arresting
cells in S phase with HU or exposure to DNA-damaging methyl
methanesulfonate (MMS) (Figure 2B). Furthermore, this muta-
tion prevented Spd1 degradation after MMS treatment even
in a yox1D background or in mitotically arrested cells(Figure 2C), where Cdt2 is highly abundant, implying that
PCNA has a critical role in this process.
From previous work, it is expected that stabilization of Spd1
would impair genome stability and S phase execution owing to
ribonucleotide reductase (RNR) inhibition [5, 13, 14]. This is
most clearly apparent in the effect of PCNAD122A on premeiotic
S phase, which is very sensitive to downregulation of RNR
activity [5]. PCNAD122A slows premeiotic S phase, but this
was suppressed by deletion of the spd1 gene (Figure 3A),
arguing that Spd1 is an important target for S phase execution.
We also observed that in the vegetative cell cycle, pcn1D122A
cells were elongated, but this was again suppressed by spd1
deletion (Figure 3B). A plausible explanation is that failure to
degrade Spd1 leads to a reduced dNTP supply for S phase
and consequent impaired replication or DNA damage, which
causes a checkpoint delay to mitotic entry. Consistent with
this interpretation, we were unable to construct a pcn1D122A
strain where the repair and replication checkpoint pathways
were inactivated by deletion of the rad3 gene, unless the
spd1 gene was deleted as well (Figure 3B). To confirm the
synthetic lethality of pcn1D122A and rad3D, we used a tempera-
ture-sensitive rad3 allele to construct the double mutant. This
pcn1D122A rad3tsmutant was inviable at the restrictive temper-
ature, and this was partially suppressed by deletion of spd1
(Figure 3C). Finally, we also observed elevated spontaneous
minichromosome loss rate in the pcn1D122A strain, which was
largely suppressed by deletion of the spd1 gene, again
implying that failure to degrade Spd1 promotes genome insta-
bility (Figure 3D). Taken together, these observations indicate
that in unperturbed cells, defects in Spd1 proteolysis caused
by the pcn1D122A mutation, and consequent effects on dNTP
supply, lead to defects in DNA replication or DNA damage
that are tolerated only in checkpoint-proficient cells. This high-
lights the importance of PCNA function in coordinating RNR
activity for DNA replication and genome stability.
It has been previously reported that the DNA damage sensi-
tivity of cdt2D mutants is not reversed by spd1 deletion [13].
In concordance with this observation, pcn1D122A cells were
sensitive to DNA-damaging agents, but this sensitivity was
not suppressed by deletion of spd1 (Figure S2A). We also
found that cdt2D phenotypes were not enhanced in a double
pcn1D122A cdt2Dmutant (Figures S2B and S2C), which argues
that both mutations act by blocking the same pathway, i.e.,
proteolysis of CRL4Cdt2 targets, and that the pcn1D122A muta-
tion does not cause other defects in PCNA function. The
simplest explanation for these findings is that whereas Spd1
is a key target of CRL4Cdt2 proteolysis in unperturbed cells,
stabilization of other targets, via cdt2D or pcn1D122A, impairs
the ability of cells to survive DNA-damaging agents. This in-
terpretation is also broadly consistent with the findings of
Holmberg et al. [5], who concluded that insufficient RNR
activity contributes to 50% of observed mutations in strains
defective in CRL4 function.
Spd1 Contains a PIP Degron that Is Important
for Its Proteolysis
Most targets of CRL4Cdt2-mediated ubiquitylation contain
a PIP degron consisting of a ‘‘classical’’ PIP consensus
sequence with TD before the aromatic residues and a posi-
tively charged amino acid downstream [19]. Spd1 does not
contain a clear match to this consensus, and no Spd1-PCNA
interaction has been detected so far. In addition, extensive
mutagenesis of Spd1 did not identify a degron sequence
[11]. Nevertheless, a weak match to this consensus is in fact
Figure 2. Chromatin-Bound PCNA Is Required
for Spd1 Proteolysis
(A) Spd1-TAP levels in a wild-type strain (1766)
and in an rfc1-44 thermosensitive mutant (2072),
treated with hydroxyurea (HU) or MMS at the
restrictive temperature (37C).
(B) Western blot analysis showing Spd1-TAP
levels after HU or MMS addition in a wild-type
strain (1766) and a pcn1D122A mutant (2649).
(C) Spd1-TAP levels after MMS treatment of
pcn1D122A yox1D (2755) cells and mitotically
arrested (nda3) pcn1D122A (2664) cells. Tubulin
is shown as a loading control.
See also Figure S1.
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722found in Spd1 at position 30 that is conserved in the Schizo-
saccharomyces genus (Figure 4A). A C-terminally truncated
Spd1 mutant (Spd11–43) retaining this PIP degron was de-
graded similar to wild-type Spd1 following HU treatment (Fig-
ure 4B). In contrast, when the N terminus of Spd1, including
this PIP box, was deleted, proteolysis after HU was signifi-
cantly reduced (Figure 4B, Spd144–124). Mutating conserved
amino acids in the PIP box (Figure 4A, Spd1MPIP) also reduced
Spd1 proteolysis after HU treatment (Figure 4B). All of these
Spd1 derivatives included a nuclear localization sequence
(NLS) as, unlike wild-type Spd1, they showed a pancellular
distribution (data not shown), and we wanted to ensure that
effects on proteolysis were not due to a secondary effect
of inefficient nuclear accumulation, which would preclude
interaction with PCNA.
Spd1 Interaction with PCNA Is Reduced by Mutation
of the PIP Box
We used bimolecular fluorescence complementation (BiFC)
[26, 27] to determine whether interaction between PCNA and
Spd1 can be detected in live cells. PCNA and Spd1 were
tagged with the N- and C-terminal domains of Venus-YFP
respectively and expressed from their native promoters. No
fluorescencewas observedwhen the tagged proteinswere ex-
pressed in a cdt2+ background (Figure 4C). However, when
coexpressed in a cdt2D background to stabilize Spd1, nuclear
YFP fluorescence was seen in all cells, irrespective of cell-
cycle stage (Figure 4C). This indicates that Spd1-PCNA inter-
action occurs in vivo and can be detected provided that the
turnover of Spd1 is blocked by lack of Cdt2. An interaction
between Spd1 and PCNA was also detectable by immunopre-
cipitation using purified PCNA and in vitro expressed Spd1
(Figure S3A).
We tested the Spd1 mutants to see how removal of the PIP
box affected interaction with PCNA. As with the proteolysisexperiments, these all included a
C-terminal NLS, and western blotting
was used to show that the mutations
did not have a significant effect on
Spd1 levels in a cdt2D mutant back-
ground (Figure S3B). Spd11–43, retaining
the PIP box, showed a BiFC signal
similar to that seen with wild-type Spd1
(Figure 4D; note that in these experi-
ments, we marked one of the strains
with amitochondrial stain to allow direct
comparison of two strains in the same
image). However, Spd144–124 showeda reduced BiFC signal, as did the Spd1MPIP mutant (Figure 4D).
We note that deleting or mutating the PIP box only reduces
and does not eliminate the BiFC signal and Spd1 proteolysis,
possibly indicating that there are other PCNA-interacting
regions in Spd1.
Taken together, the results described here indicate that the
role of the DNA damage checkpoint activation in Spd1 degra-
dation is simply to provide an adequate level of Cdt2 at times
of the cell cycle when levels are low, and that high Cdt2 levels
are not sufficient to promote Spd1 degradation. Significantly,
we demonstrate that the critical step in Spd1 proteolysis,
and therefore in RNR upregulation, is the interaction of Spd1
with DNA-bound PCNA. Because PCNA serves as an essential
polymerase processivity factor in S phase, as well as pro-
moting repair synthesis by pol d and other repair polymerases,
this provides a direct mechanism to synchronize DNA syn-
thesis with stimulation of RNR to upregulate dNTP produc-
tion. This mechanism is distinct from proteolysis of Sml1 in
S. cerevisiae. In this organism, which lacks the CRL4Cdt2
pathway, checkpoint activation in S phase and after DNA
damage leads to Sml1 phosphorylation, and this modified
version of the protein is ubiquitylated by the Rad6-Ubr2-
Mub1 E2/E3 ubiquitin ligase complex [28, 29].
The type 1a class of RNRs, found in eukaryotes and eubac-
teria, consists of a heterotetramer composed of two large
catalytic R1 subunits and two small R2 subunits that generate
the tyrosyl free radical required for catalysis (for reviews see
[1, 2]). Spd1 inhibits RNR activity most probably by binding
to the R1/Cdc22 subunit [10], although it has also been impli-
cated in promoting the nuclear import of the R2/Suc22
subunit, facilitating R1-R2 interactions, and binding to the R2
subunit [11]. One implication of our findings is that Spd1 is
degraded via interaction with a nuclear protein, whereas its
mode of inhibition appears to require interaction with R1/
Cdc22, which is predominantly cytoplasmic. RNR is thought
Figure 3. PCNAD122A-Induced Defects Are Suppressed by spd1 Deletion
(A) pat1 strains also containing pcn1D122A (2912), pcn1D122A spd1D (2915), or spd1D (2930) mutations were arrested in G1 by nitrogen starvation and then
released from the block at 34C to inactivate Pat1 and induce meiosis. The progress of premeiotic S phase was followed by flow cytometry.
(B) Upper panels: images of exponentially growing cells from wild-type (137), spd1D (2671), rad3D (1811), pcn1D122A (2738), pcn1D122A spd1D (2747), and
pcn1D122A spd1D rad3D (2842) cultures. Lower panel: average cell length 6 SD (150 cells were measured for each strain).
(C) Viability of wild-type (137), pcn1D122A (2738), spd1D (2671), rad3ts (2839), pcn1D122A rad3ts (2887),pcn1D122A spd1D rad3ts (2888), spd1D rad3ts (2889), and
pcn1D122A spd1D (2747) strains on YE3S at 26C and 37C analyzed by spot tests.
(D) Rate of minichromosome loss in wild-type (2836), pcn1D122A (2898), spd1D (2885), and pcn1D122A spd1D (2900) strains.
See also Figure S2.
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locating from the nucleus to the cytoplasm to increase RNR
activity. In a model to reconcile these observations, Spd1
may shuttle between nucleus and cytoplasm and, in theabsence of DNA synthesis, Spd1 is stable during nuclear
transit (Figure 4E, left panel). During S phase or DNA synthesis
associated with repair, nuclear Spd1 interacts with chromatin-
associated PCNA, leading to its ubiquitylation and proteolysis,
Figure 4. Spd1 and PCNA Interact In Vivo, and a PIP Box in Spd1 Is Important for This Interaction
(A) Identification of a sequence (orange bar and box) in S. pombe Spd1 (gray bar) that partially matches the PIP degron consensus sequence. Other
sequences shown are (bottom to top) corresponding region of S. japonicus Spd1 (SjSpd1), PIP degrons in S. pombe Cdt1 (SpCdt1_301 and SpCdt1_28
[18]), PIP degron and PIP box consensus sequences [25], and the mutated sequence of Spd1MPIP. Green and blue bars at bottom show the Spd11–43
and Spd144–124 deletion mutants. The cyan bar labeled ‘‘R1’’ represents the location of sequence similarity with a region of Sm11 known to interact with
the R1 subunit of RNR [11].
(B)Western blot analysis of Spd1-YFP-NLS levels after HU addition in awild-type strain (2672), the Spd11–43mutant (2612), the Spd144–124mutant (2744), and
the Spd1MPIP mutant (2673). Tubulin is shown as a loading control.
(C) Bimolecular fluorescence complementation (BiFC) of exponentially growing live cells expressing VN173-pcn1 and spd1-VC155 in a wild-type (2536) and
in a cdt2D (2546) background.
(D) Comparison of the intensity of BiFC in exponentially growing live cells. A wild-type (2752) and an spd11–43 (2750) strain (left panels), a wild-type (2752) and
an spd144–124 (2751) strain (middle panels), and a wild-type (2752) and an spd1MPIP (2748) strain (right panels) were compared. Phase (blue) and BiFC signal
(green) channels are shownmerged (upper panels). In all combinations, cells carrying themutation in Spd1were stainedwithMitoTracker Red to allow direct
comparison between the two strains (lower panels). All strains were in a cdt2D background to stabilize Spd1; comparison of Spd1 levels in these strains is
shown in Figure S3B.
(E)Model for RNR activity control by PCNA. Left panel represents an unperturbed cell in G1, G2, orMphase that is not subject to DNAdamage. Spd1 shuttles
between nucleus and cytoplasm, interacting with and inhibiting RNR in the cytoplasm and possibly interacting with free PCNA in the nucleus. CRL4Cdt2 does
not ubiquitylate nuclear Spd1, as PCNA is not DNA bound. Right panel represents the situation when S phase starts or DNA synthesis associated with DNA
damage repair is occurring. Spd1 shuttles from cytoplasm to nucleus, but in the nucleus, following interaction with chromatin-bound PCNA, it is ubiquity-
lated and proteolyzed. The net reduction in Spd1 levels leads to RNR activation.
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tion (Figure 4E, right panel). Spd1 proteolysis may also
contribute to RNR activation by reducing nuclear import of
the R2/Suc22 subunit, thus increasing cytoplasmic R2/Suc22
levels, although themechanism of this is unclear [11]. Although
we note that the active form of the enzyme is thought to
be cytoplasmic, the PCNA-Spd1 interaction potentially can
target RNR to sites of DNA synthesis. In mammalian cells,
Tip60 has been reported to localize RNR to sites of DNA dam-
age, which may be important for providing adequate dNTP at
repair sites at times of the cell cycle when dNTP pools are
low [30].
So far, no Spd1 ortholog has been identified in metazoa,
but the small size of this protein and its low sequence conser-
vation through evolution makes detection of any related pro-
teins difficult. In addition, the intrinsically disordered nature
of Spd1 [11] could mean that proteins without any sequence
similarity could perform similar roles in higher organisms.
However, given the conservation of the CRL4Cdt2 pathway,
identification of mammalian protein inhibitors of RNR might
be facilitated by inactivation of this mechanism.
Proteolysis of CRL4Cdt2 targets triggered by PCNA chro-
matin binding is emerging as an important mechanism in
DNA replication control (reviewed in [25]). Degradation of
Cdt1 blocks Mcm chromatin binding directly, whereas p21
proteolysis leads to nuclear export of the Cdc6 licensing factor
[21], and downregulation of Set8 in S phase also seems to be
important for blocking rereplication [31, 32]. Our results here,
showing that an inhibitor of the elongation step of replication
is degraded simultaneously with destruction of licensing
activators, emphasize how PCNA activation of CRL4Cdt2 is a
master switch in the transition from G1 to S phase.
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